INmune Bio Inc (INMB)
1.39
+3.73%
INmune Bio Inc (INMB) is currently trading at $1.39. This represents a gain of 3.73% from the previous session. With a market capitalization of $0.04B, INMB is a key component of the Health Care sector. Investors looking to trade INMB should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Get 15 Free Stocks on Moomoo →
T&Cs Apply. Trade INMB commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, INmune Bio Inc (INMB) shows a bullish trend. Analysts are watching the 1.50 level closely.
Fundamentals
Mkt Cap0.04B
P/E Ratio0.0000
Volume1,010,487
60-Day Technical Chart
Advanced Charting
Need more indicators for INMB? Use the world's #1 platform.
Open INMB on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $1
| Metric |
INMB +3.73% |
RXT -7.53% |
GORO -10.03% |
FATE -8.64% |
|---|---|---|---|---|
| Price | $1.39 | $1.35 | $1.39 | $1.48 |
| Mkt Cap | $0.04B | $0.34B | $0.23B | $0.17B |
| - | View → | View → | View → |
Latest Headlines
Alzheimer’s therapy XPro1595 nears key trial as INmune Bio details Phase 3 path
Stock Titan • Feb 23, 2026
INmune Bio (INMB) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
Yahoo Finance • Nov 6, 2025
INmune Bio stock falls after new Alzheimer’s trial data
Investing.com • Dec 1, 2025
Can INmune Bio (NASDAQ:INMB) Afford To Invest In Growth?
simplywall.st • Dec 9, 2025
INmune Bio (INMB) Loses 23.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Nasdaq • Sep 8, 2025
● Gemini Agentic AI Analyst Insight for INMB
Market Education
- Exploring Gann Trading: An Insightful Guide for Traders Jun 2, 2024
- Stocks with Cash and Low Debt Dec 10, 2023
- Institutions vs Retail Traders - Showdown, Apes are winning May 24, 2021
External Research